NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Go back to NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
(NASDAQ: NRXP) Delayed: 4.08 -0.4 (8.93%)
Previous Close $4.48    52 Week High
Open $4.35    52 Week Low
Day High $4.42    P/E N/A 
Day Low $4.02    EPS
Volume 719,882